Browsing by Author Vicent, S. (Silvestre)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 23  next >
Issue DateTitleTypeAuthor(s)
2004Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancerArticuloPio, R. (Rubén); Zudaire, I. (Isabel); Pino, I. (Irene); Castaño, Z. (Z.); Zabalegui, N. (Natalia); Vicent, S. (Silvestre); Garcia-Amigot, F. (Fermín); Odero, M.D. (Maria Dolores); Lozano, M.D. (María Dolores); Garcia-Foncillas, J. (Jesús); Calasanz-Abinzano, M.J. (Maria Jose); Montuenga-Badia, L.M. (Luis M.)
2004Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesisArticuloBlanco, D. (D.); Vicent, S. (Silvestre); Elizegi, E. (E.); Pino, I. (Irene); Fraga, M.F. (Mario F.); Esteller, M. (Manel); Saffiotti, U. (Umberto); Lecanda, F. (Fernando); Montuenga-Badia, L.M. (Luis M.)
2003Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancerArticuloPino, I. (Irene); Pio, R. (Rubén); Toledo, G. (Gemma); Zabalegui, N. (Natalia); Vicent, S. (Silvestre); Rey, N. (Natalia); Lozano, M.D. (María Dolores); Torre, W. (Wenceslao); Garcia-Foncillas, J. (Jesús); Montuenga-Badia, L.M. (Luis M.)
2002CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potentialArticuloManzano, R.G. (Ramón G.); Montuenga-Badia, L.M. (Luis M.); Dayton, M. (M.); Dent, P. (P.); Kinoshita, I. (Ichiro); Vicent, S. (Silvestre); Gardner, G.J. (Ginger J.); Nguyen, P. (PhuongMai); Choi, Y.H. (Yung-Hyun); Trepel, J. (Jane); Auersperg, N. (N.); Birrer, M.J. (Michael J.)
2023Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancerOtrosEntrialgo-Cadierno, R. (Rodrigo); Cueto-Ureña, C. (Cristina); Welch, C. (Connor); Feliu, I. (Iker); Macaya, I. (Irati); Vera, L. (Laura); Morales-Urteaga, X. (Xabier); Vietti-Michelina, S. (Sandra); Scaparone, P. (Pietro); Lopez, I. (Inés); Darbo, E. (Elodie); Erice, O. (Oihane); Vallejo-Blanco, A. (Adrián); Moreno, H. (Haritz); Goñi-Salaverri, A. (Ainhoa); Lara-Astiaso, D. (David); Halberg, N. (Nils); Cortés-Dominguez, I. (Iván); Guruceaga, E. (Elizabeth); Ambrogio, C. (Chiara); Lecanda, F. (Fernando); Vicent, S. (Silvestre)
2021Elevated NSD3 histone methylation activity drives squamous cell lung cancerArticuloYuan, G. (Gang); Flores, N.M. (Natasha M.); Hausmann, S. (Simone); Lofgren, S.M. (Shane M.); Kharchenko, V. (Vladlena); Angulo-Ibanez, M. (Maria); Sengupta, D. (Deepanwita); Lu, X. (Xiaoyin); Czaban, I. (Iwona); Azhibek, D. (Dulat); Vicent, S. (Silvestre); Fischle, W. (Wolfgang); Jaremko, M. (Mariusz); Fang, B. (Bingliang); Wistuba, I.I. (Ignacio I.); Chua, K.F. (Katrin F.); Roth, J.A. (Jack A.); Minna, J.D. (John D.); Shao, N.Y. (Ning-Yi); Jaremko, L. (Lukasz); Mazur, P.K. (Pawel K.); Gozani, O. (Or)
2004ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumoursArticuloVicent, S. (Silvestre); Lopez-Picazo, J.M. (José M.); Toledo, G. (Gemma); Lozano, M.D. (María Dolores); Torre, W. (Wenceslao); Garcia-Corchon, C. (C.); Quero, C. (C.); Soria, J.C. (Jean-Charles); Martin-Algarra, S. (Salvador); Manzano, R.G. (Ramón G.); Montuenga-Badia, L.M. (Luis M.)
2020FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their coexpression may predict FGFR-targeted therapy efficacyArticuloQuintanal-Villalonga, Á. (Álvaro); Ferrer, I. (Irene); Guruceaga, E. (Elizabeth); Cirauqui, C. (Cristina); Marrugal, Á. (Ángela); Ojeda, L. (Laura); García, S. (Santiago); Zugazagoitia, J. (Jon); Muñoz-Galván, S. (Sandra); López-Ríos, F. (Fernando); Montuenga-Badia, L.M. (Luis M.); Vicent, S. (Silvestre); Molina-Pinelo, S. (Sonia); Carnero, A. (Amancio); Paz-Ares, L. (Luis)
2021FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targetedArticuloVallejo-Blanco, A. (Adrián); Erice, O. (Oihane); Entrialgo-Cadierno, R. (Rodrigo); Feliu, I. (Iker); Guruceaga, E. (Elizabeth); Perugorria, M.J. (María J.); Olaizola, P. (Paula); Muggli, A. (Alexandra); Macaya, I. (Irati); O’Dell, M. (Michael); Ruiz-Fernandez-de-Cordoba, B. (Borja); Ortiz-Espinosa, S. (Sergio); Hezel, A.F. (Aram F.); Arozarena, I. (Imanol); Lecanda, F. (Fernando); Avila, M.A. (Matías Antonio); García-Fernández-de-Barrena, M. (Maite); Evert, M. (Matthias); Ponz-Sarvise, M. (Mariano); Calvisi, D.F. (Diego F.); Banales, J.M. (Jesús M.); Vicent, S. (Silvestre)
2019Genetic mouse models as in vivo tools for cholangiocarcinoma researchArticuloErice, O. (Oihane); Vallejo-Blanco, A. (Adrián); Ponz-Sarvise, M. (Mariano); Saborowski, M. (Michael); Vogel, A. (Arndt); Calvisi, D.F. (Diego F.); Saborowski, A. (Anna); Vicent, S. (Silvestre)
2024GeNNius: an ultrafast drug-target interaction inference method based on graph neural networksArticuloVeleiro, U. (Uxía); Fuente-Arias, J. (Jesús) de la; Serrano-Sanz, G. (Guillermo); Pizurica, M. (Marija); Casals-Baena, M. (Mikel); Pineda-Lucena, A. (Antonio); Vicent, S. (Silvestre); Ochoa-Álvarez, I. (Idoia); Gevaert, O. (Oliver); Hernaez, M. (Mikel)
2001Hyperplasia of alveolar neuroendocrine cells in rat lung carcinogenesis by silica with selective expression of proadrenomedullin-derived peptides and amidating enzymesArticuloElizegi, E. (E.); Pino, I. (Irene); Vicent, S. (Silvestre); Blanco, D. (D.); Saffiotti, U. (Umberto); Montuenga-Badia, L.M. (Luis M.)
2020Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T CellsArticuloBaraibar-Argota, I. (Iosune); Román, M. (Marta); Rodríguez-Remírez, M. (M.); Lopez, I. (Inés); Vilalta, A. (Anna); Guruceaga, E. (Elizabeth); Ecay, M. (Margarita); Collantes, M. (María); Lozano-Moreda, T. (Teresa); Alignani, D. (Diego); Puyalto, A. (Ander); Oliver, A. (Ana); Ortiz-Espinosa, S. (Sergio); Moreno, H. (Haritz); Torregrosa, M.S. (María Soledad); Rolfo, C. (Christian); Caglevic, C. (Christian); Garcia-Ros, D. (David); Villalba-Esparza, M. (María); Andrea, C.E. (Carlos Eduardo) de; Vicent, S. (Silvestre); Pio, R. (Rubén); Lasarte, J.J. (Juan José); Calvo-González, A. (Alfonso); Ajona, D. (Daniel); Gil-Bazo, I. (Ignacio)
23-Mar-2020Identification of novel oncogene dependencies in mutant KRAS-driven epithelial tumours: the role of the transcription factor FOSL1TesisVallejo-Blanco, A. (Adrián)
2018KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old targetArticuloRomán, M. (Marta); Baraibar-Argota, I. (Iosune); Lopez, I. (Inés); Nadal, E. (Ernest); Rolfo, C. (Christian); Vicent, S. (Silvestre); Gil-Bazo, I. (Ignacio)
2006Las metástasis óseas del cáncerArticuloVicent, S. (Silvestre); Luis-Ravelo, D. (Diego); Anton, I. (Iker); Hernandez, I. (I.); Martinez, S. (Sergio); De-las-Rivas, J. (Javier); Gurpide, A. (Alfonso); Lecanda, F. (Fernando)
2004Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in PatientsArticuloVicent, S. (Silvestre); Garayoa, M. (Mercedes); Lopez-Picazo, J.M. (José M.); Lozano, M.D. (María Dolores); Toledo, G. (Gemma); Thunnissen, F.B. (Frederick B.); Manzano, R.G. (Ramón G.); Montuenga-Badia, L.M. (Luis M.)
2019p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinomaArticuloGiordano, F. (Federica); Vaira, V. (Valentina); Cortinovis, D. (Diego); Bonomo, S. (Sara); Goedmakers, J. (Joyce); Brena, F. (Federica); Cialdella, A. (Annamaria); Ianzano, L. (Leonarda); Forno, I. (Irene); Cerrito, M.G. (Maria Grazia); Giovannoni, R. (Roberto); Ferri, G.L. (Gian Luca); Tasciotti, E. (Ennio); Vicent, S. (Silvestre); Damarco, F. (Francesco); Bosari, S. (Silvano); Lavitrano, M. (Marialuisa); Grassilli, E. (Emanuela)
2023Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaArticuloLarrayoz, M. (Marta); García-Barchino, M.J. (María José); Celay, J. (Jon); Etxebeste-Mitxeltorena, A. (Amaia); Jiménez-Andrés, M. (Maddalen); Perez, C. (Cristina); Ordóñez-Ciriza, R. (Raquel); Cobaleda, C. (César); Botta, C. (Cirino); Fresquet, V. (Vicente); Roa, S. (Sergio); Goicoechea, I. (Ibai); Maia, C. (Catarina); Lasaga, M. (Miren); Chesi, M. (Marta); Bergsagel, P.L. (P. Leif); Larrayoz, M.J. (María J.); Calasanz-Abinzano, M.J. (Maria Jose); Campos-Sanchez, E. (Elena); Martínez-Cano, J. (Jorge); Panizo, C. (Carlos); Rodriguez-Otero, P. (Paula); Vicent, S. (Silvestre); Roncador, G. (Giovanna); Gonzalez, P. (Patricia); Takahashi, S. (Satoru); Katz, S.G. (Samuel G.); Walensky, L.D. (Loren D.); Ruppert, S.M. (Shannon M.); Lasater, E.A. (Elisabeth A.); Amann, M. (Maria); Lozano-Moreda, T. (Teresa); Llopiz, D. (Diana); Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Planell, N. (Núria); Gomez-Cabrero, D. (David); Kudryashova, O. (Olga); Kurilovich, A. (Anna); Revuelta, M.V. (Maria V.); Cerchietti, L. (Leandro); Aguirre-Ena, X. (Xabier); San-Miguel, J.F. (Jesús F.); Paiva, B. (Bruno); Prosper-Cardoso, F. (Felipe); Martinez-Climent, J.A. (José Ángel)
2023Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerArticuloMacaya, I. (Irati); Román, M. (Marta); Welch, C. (Connor); Entrialgo-Cadierno, R. (Rodrigo); Salmon, M. (Marina); Santos, A. (Alba); Feliu, I. (Iker); Kovalski, J. (Joanna); Lopez, I. (Inés); Rodríguez-Remírez, M. (M.); Palomino-Echeverría, S. (Sara); Lonfgren, S.M. (Shane M.); Ferrero, M. (Macarena); Calabuig-Fariñas, S. (Silvia); Ludwig, I.A. (Iziar Amaia); Lara-Astiaso, D. (David); Jantus-Lewintre, E. (Eloisa); Guruceaga, E. (Elizabeth); Narayanan, S. (Shruthi); Ponz-Sarvise, M. (Mariano); Pineda-Lucena, A. (Antonio); Lecanda, F. (Fernando); Ruggero, D. (Davide); Khatri, P. (Purvesh); Santamaria, E. (Enrique); Fernandez-Irigoyen, J. (Joaquín); Ferrer, I. (Irene); Paz-Ares, L. (Luis); Drosten, M. (Mathias); Barbacid, M. (Mariano); Gil-Bazo, I. (Ignacio); Vicent, S. (Silvestre)